IP Library Granted Patent US 9,283,036
Granted Patent B2
US 9,283,036 · App. 12/100,223 · Granted Mar 15, 2016

Laser therapy apparatus with controlled optical coherence

Inventor: Sean Xiaolu Wang (Wilmington, DE)
Assignee: BWT Property, Inc.
A61B18/20A61B2018/00636
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,036
App. No.
12/100,223
Granted
Mar 15, 2016
Kind
B2
Abstract

A laser therapy method and apparatus is disclosed. The optical coherence property of the therapy laser is actively controlled to provide optimum therapy results for difference types of biological tissue and body parts.

Claims (36)

1. A method for using an optimized laser therapy device for a subject biological tissue, the method comprising the steps of:

providing a laser element to produce a laser beam;

causing the laser beam to enter the biological tissue and produce an interference induced speckle pattern of intensity; and

controlling a coherence length of the laser beam to control the dimensions of the speckle pattern so as to achieve an optimized laser therapy result.

2. The method of claim 1 , wherein the laser element comprises a semiconductor laser diode.

3. The method of claim 2 , wherein the coherence length of the laser beam is controlled by controlling a spectral linewidth of said laser diode with an external cavity.

4. The method of claim 3 , wherein the external cavity comprises a wavelength-selective element.

5. The method of claim 4 , wherein the wavelength-selective element comprises a volume Bragg grating.

6. The method of claim 1 , wherein the coherence length of the laser beam is controlled by applying a modulation scheme onto the laser element to control a spectral linewidth of said laser element.

7. The method of claim 1 , wherein the coherence length of the laser beam is controlled by an optical component positioned in a path of the laser beam.

8. The method of claim 1 , further comprising a step of controlling an illumination time and a physical position of the laser beam.

9. The method of claim 1 , wherein the speckle pattern induces spatially inhomogeneous photochemical processes.

10. A method for using an optimized laser therapy device for a subject biological tissue, the method comprising the steps of:

providing a laser element to produce at least two laser beams;

causing the laser beams to enter the biological tissue and produce an interference pattern of intensity; and

controlling a coherence length of the laser beams and an angle between the laser beams to control the dimensions of the interference pattern as to achieve an optimized laser therapy result.

11. The method of claim 10 , further comprising a step of controlling an illumination time and a physical position of the laser beams.

12. The method of claim 10 , wherein the laser element comprises a semiconductor laser diode.

13. The method of claim 10 , wherein the coherence length of the laser beam is controlled by controlling a spectral linewidth of said laser diode with an external cavity.

14. The method of claim 13 , wherein the external cavity comprises a wavelength-selective element.

15. The method of claim 14 , wherein the wavelength-selective element comprises a volume Bragg grating.

16. The method of claim 10 , wherein the coherence length of the laser beam is controlled by applying a modulation scheme onto the laser element to control a spectral linewidth of said laser element.

17. The method of claim 10 , wherein the coherence length of the laser beam is controlled by an optical component positioned in a path of the laser beam.

18. The method of claim 10 , wherein the interference pattern induces spatially inhomogeneous photochemical processes.

19. An optimized laser therapy device for a subject biological tissue comprising:

means for producing at least one laser beam;

means for causing the at least one laser beam to enter the biological tissue and produce an interference pattern of intensity; and

means for controlling a coherence length of the at least one laser beam to control the dimensions of the interference pattern as to achieve an optimized laser therapy result.

20. The device of claim 19 , further comprising means for controlling an illumination time and a physical position of the laser beams.

21. The device of claim 19 , wherein the laser element comprises a semiconductor laser diode.

22. The device of claim 19 , wherein the coherence length of the laser beam is controlled by controlling a spectral linewidth of said laser diode with an external cavity.

23. The device of claim 22 , wherein the external cavity comprises a wavelength-selective element.

24. The device of claim 23 , wherein the wavelength-selective element comprises a volume Bragg grating.

25. The device of claim 19 , wherein the coherence length of the laser beam is controlled by applying a modulation scheme onto the laser element to control a spectral linewidth of said laser element.

26. The device of claim 19 , wherein the coherence length of the laser beam is controlled by an optical component positioned in a path of the laser beam.

27. The device of claim 19 , wherein the interference pattern induces spatially inhomogeneous photochemical processes.

Assignments (2)
SECURITY INTEREST Recorded Jan 3, 2024
From: LITECURE LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066162/0761 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2020
From: BWT PROPERTY, INC.; PRYOR, BRIAN; WANG, SEAN XIAOLU
To: LITECURE LLC
Reel/Frame 054129/0653 →
Continuity (2)
Provisional Application 60910855 · Apr 10, 2007
Related Publication 20080255638A1 · Oct 16, 2008